Company: CHNR
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001079973-25-000143
Chunk: 65

Company: CHINA NATURAL RESOURCES INC
Filing Date: 2025-01-27
Form: POS AM
Chunk 65
---
 increase our risk of liability; |

| · |     | complications in the integration of acquired businesses or                                 
 diminished prospects, including as a result of the domestic and global economic downturns; |

| · |     | failure to generate the expected financial results related 
 to an acquisition in a timely manner or at all;            |

| · |     | failure to accurately forecast the impact of an acquisition 
 transaction; and                                            |

| · |     | implementation or remediation of effective controls, procedures, 
 and policies for acquired businesses.                            |

| 34 |

The manufacturing and sale of pharmaceutical
and healthcare products in China are each subject to extensive and evolving government regulations and supervision. If we enter these
industries, any unfavorable regulatory changes in these industries may also increase our compliance burden and materially and adversely
affect our business, profitability and prospects. Certain other laws, rules and regulations may affect the pricing of, demand for and
sales of pharmaceutical and healthcare products (such as those laws relating to the procurement, prescription and dispensing of drugs
by hospitals, other medical institutions and retail pharmacies), government funding for private healthcare and medical services, and
the inclusion of products in the drugs catalogs for national basic medical insurance, on-the-job injury insurance and maternity insurance
jointly promulgated by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security of the
PRC.

Furthermore, the introduction of new
services and products, or the entry into other sectors, may require us to comply with additional, yet undetermined, laws and regulations.
Compliance may require obtaining appropriate permits, licenses or certificates as well as expending additional resources to monitor developments
in the relevant regulatory environment. Failure to adequately comply with these additional laws and regulations may delay, or possibly
prevent, some of our products or services from being offered, which may have a material adverse effect on our business, financial condition
and results of operations.

Risks Relating to Our Financial Condition and Business

We have incurred losses from operations in each of the preceding three fiscal years of 2021, 2022 and 2023 and for the six months ended June 30, 2023 and 2024, and there is no assurance that we will generate profits from operations in the future.

For the three years
ended December 31, 2021, 2022 and 2023 and the six months ended June 30, 2023 and 2024, we incurred operating losses of CNY10.48